Cargando…
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the...
Autor principal: | Brown, Ronald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996517/ https://www.ncbi.nlm.nih.gov/pubmed/33652582 http://dx.doi.org/10.3390/medicina57030199 |
Ejemplares similares
-
Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021) -
The dawn of mRNA vaccines: The COVID-19 case
por: Verbeke, Rein, et al.
Publicado: (2021) -
Liposomes and mRNA: Two technologies together create a COVID-19 vaccine
por: Gregoriadis, Gregory
Publicado: (2021) -
Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
por: Weng, Yuhua, et al.
Publicado: (2021) -
Post-COVID mRNA-vaccine IgG4 shift: worrisome?
por: Kadkhoda, Kamran
Publicado: (2023)